Data from the Childhood Cancer Survivor Study (CCSS), a retrospective cohort study of children diagnosed with cancer from 1970–1999 at 31 participating institutions, suggests the strategy of modifying therapy to reduce the occurrence of late-effects, and promotion of early detection, is significantly reducing the observed late mortality in this population.
Presented by Gregory T. Armstrong, MD, MSCE, St. Jude Children’s Research Hospital, Memphis, TN, at ASCO 2015.
